ArticleBMC ophthalmology2025
Efficacy and safety evaluation of phacoemulsification with intraocular lens implantation combined with goniotomy versus combined with trabeculectomy in advanced pseudoexfoliative glaucoma with cataract.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the efficacy and safety of phacoemulsification with intraocular lens implantation (PEI) combined with 120° goniotomy (GT) versus PEI combined with trabeculectomy (Trab) in advanced Pseudoexfoliative glaucoma (PXG) with cataracts.
methodsA retrospective study included 68 advanced PXG with cataract patients (68 eyes): 32 underwent PEI + GT and 36 underwent PEI + Trab. The visual acuity, intraocular pressure(IOP), the number of glaucoma medications, surgical success rate, complications, postoperative interventions, surgery duration, and quality of life (EQ-5D-5L) were recorded preoperatively and at 1, 3, 6, and 12 months postoperatively.
resultsThe PEI + GT group had a higher 1-month IOP than PEI + Trab (15.7 ± 1.7 vs. 13.9 ± 2.3 mmHg; P<0.05). Both groups experienced a significant reduction in the IOP and the number of medications used postoperatively (all P<0.05).The cumulative success rate and early complication incidence were comparable between the groups (P>0.05).PEI + GT demonstrated significantly lower rates of late complications and postoperative interventions, shorter operative time (16.8 ± 3.1 vs. 34.5 ± 5.5 min), and higher postoperative quality of life (EQ-5D-5L) compared to PEI + Trab (all P < 0.05).
conclusionBoth PEI + GT and PEI + Trab effectively reduced IOP and glaucoma medication use in PXG patients with cataract. However, PEI + GT demonstrated shorter surgery duration, fewer late complications, reduced need for postoperative interventions, better surgery safety, and higher postoperative quality of life than PEI + Trab.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.